. Author manuscript; available in PMC: 2016 Nov 4.

Published in final edited form as: AIDS Behav. 2007 Mar;11(2):161–173. doi: 10.1007/s10461-006-9133-3

Table 1.

Amount of variance in HIV-1 RNA viral load explained by electronic drug monitoring antiretroviral adherence estimates at each assessment point by assessment interval among HIV-positive outpatients

Assessment interval	Study assessment point R²; β co-efficient (SE)
Assessment interval	2-month (n = 92)	3-month (n = 85)	4-month (n = 76)	6-month (n = 90)
1 day	.10; −.84 (.30)^**	.10; −.86 (.30)^**	.01; −.23 (.31)^**	.11; −.89 (.32)^**
2 days	.12; −.94 (.31)^**	.08; −.84 (.34)^**	.01; −.30 (.33)^**	.15; −1.1 (.31)^**
3 days	.18; −1.3 (.31)^**	.06; −.76 (.35)^*	.03; −.45 (.33)^*	.12; −.99 (.29)^**
28 days	.19; −1.5 (.35)^**	.08; −.95 (.39)^*	.01 −.30 (.37)^**	.05; −.71 (.37)^*

P < .05.

^**

P < .01